CB1R AS A POTENTIAL THERAPEUTIC TARGET IN CRBN DEFICIENCY-ASSOCIATED MENTAL RETARDATION
Main Authors: | Alba Hermoso-López, Carlos Costas-Insua, Carlos Montero-Fernández, Estefanía Moreno, Alicia Álvaro-Blázquez, David Martín-Gutiérrez, Irene B. Maroto-Martínez, Rebeca Diez-Alarcia, Leyre Urigüen, Vicent Casadó, Ignacio Rodríguez-Crespo, Manuel Guzmán |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2023-10-01
|
Series: | IBRO Neuroscience Reports |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2667242123018250 |
Similar Items
-
The CB1 receptor interacts with cereblon and drives cereblon deficiency-associated memory shortfalls
by: Carlos Costas-Insua, et al.
Published: (2024-03-01) -
Ribosomal Protein S6 Hypofunction in Postmortem Human Brain Links mTORC1-Dependent Signaling and Schizophrenia
by: Inés Ibarra-Lecue, et al.
Published: (2020-03-01) -
Regulation of AMPK Activity by CRBN Is Independent of the Thalidomide-CRL4<sup>CRBN</sup> Protein Degradation Axis
by: Seung-Joo Yang, et al.
Published: (2021-05-01) -
DISCOVERING THE MOLECULAR MECHANISMS UNDERLYING CANNABIS-INDUCED INCREASED RISK OF SCHIZOPHRENIA: EVALUATION OF THE AKT/MTOR/S6 PATHWAY STATUS IN A DOUBLE HIT RODENT MODEL.
by: Silvia Iñiguez-Barrio, et al.
Published: (2023-10-01) -
Neuronal Cannabinoid CB<sub>1</sub> Receptors Suppress the Growth of Melanoma Brain Metastases by Inhibiting Glutamatergic Signalling
by: Carlos Costas-Insua, et al.
Published: (2023-04-01)